Novel chemokine biomarkers in melanoma †
The Journal of Pathology · 2024
DOI: 10.1002/path.6323 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pathology, 2024. Verfasst von Alessio Giubellino und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Chemokines, Melanoma, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The melanoma tumor microenvironment is a complex milieu of cancer, inflammatory, and stromal cells. In this context, chemokines play a pivotal role in recruiting inflammatory cells and influence the tumor, exerting both pro‐tumorigenic and anti‐tumoral roles. Interactions between these cells is what ultimately hold together and transform the tumor into an efficient machine. A recent study found that chemokines CCL8, CCL15, and CCL20 were upregulated in melanoma cells when co‐cultured with macrophages and were associated with poor survival rates. CCL8 and CCL15 also stimulated melanoma cell growth, invasion, and metastasis, and were highly expressed in tumors prone to metastasize, suggesting these chemokines are attractive and independent biomarkers. Understanding the intricated interactions within the tumor microenvironment could lead to prognostic biomarkers and to the development of new therapeutic strategies for melanoma. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
- Center for Immunology, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Alessio Giubellino, Sara E Hamilton
Zitieren
APA
Giubellino, A., & Hamilton, S. E. (2024). Novel chemokine biomarkers in melanoma †. The Journal of Pathology. https://doi.org/10.1002/path.6323
Vancouver
Giubellino A, Hamilton SE. Novel chemokine biomarkers in melanoma †. The Journal of Pathology. 2024. doi:10.1002/path.6323
BibTeX
@article{Giubellino2024,
author = {Giubellino, Alessio and Hamilton, Sara E},
title = {Novel chemokine biomarkers in melanoma †},
journal = {The Journal of Pathology},
year = {2024},
doi = {10.1002/path.6323}
}
EUVIMED